Menu
Recruiting NCT06676137

An Observational Study of Coronary Microvascular Disease of China

Observational Coronary Microvascular Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Coronary Microvascular Disease. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

China Coronary Microvascular Disease(CCMD) Registry

Overview

Non-obstructive coronary heart disease refers to patients with angina pectoris without significant narrowing of the epicardial vessels. Coronary microvascular disease(CMD) is a kind of non-obstructive coronary heart disease, and its clinical detection rate is increasing, seriously affecting the quality of life of patients, and increasing the risk of cardiovascular adverse events, but its mechanism has not been fully understood. This study will prospectively collect patients who meet the diagnosis of CMD, observe the development and outcome of the disease, and explore its occurrence and development mechanism.

Primary outcome measures

  • Establish a Registry of CMD patients in China [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Angina symptoms
  • Objective evidence of myocardial ischemia
  • Coronary angiography was normal,irregular tube wall, or stenosis <50%

Exclusion criteria

  • People under the age of 18
  • Non-cardiogenic chest pain and other heart conditions such as variant angina, cardiomyopathy, myocarditis or valvular heart disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

China · 1 center
  • Fuwai central China cardiovascular hospotial — Zhengzhou

Identifiers

NCT: NCT06676137 · HenanICE202410

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗